Somnomed

SomnoMed is a publicly traded company (ASX:SOM) founded in 2004 in Sydney, Australia. The North American office, located in Frisco, Texas was opened in 2006; introducing their leading device technology to patients in America. To date there have been over 350,000 patients around the world who have been treated with SomnoDent therapy.

As the global leader in COAT (Continuous Open Airway Therapy) SomnoMed provides clinically proven diagnostic and treatment options for sleep-related breathing disorders such as obstructive sleep apnea (OSA) and sleep bruxism.

Visit for more information or to find obstructive sleep apnea (OSA) treatment today.

SomnoMed provides treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent® becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea (OSA). More than 250,000 patients around the world have treated their mild to moderate obstructive sleep apnea (OSA) with SomnoDent oral device therapy. Worn during sleep and fitted by a dental sleep specialist, the SomnoDent line of oral appliances are customized to offer superior comfort and quality to each individual patient.

At SomnoMed, we keep the patient at the center of our focus and know that successful treatment is much more than just the device. With our history of innovation, commitment to connecting physicians and dentists, SomnoMed provides patients with the products and services they need to return to enjoying their lives.

SomnoMed is a publicly traded company (ASX:SOM) founded in 2004 in Sydney, Australia. The North American office, located in Frisco, Texas was opened in 2006.